project id: TCGA-MESO; case submitter id: TCGA-MQ-A4LI; source center: 23; state: released; a260 a280 ratio: 1.78; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 0.66; rna integrity number: 7.1; age at index: 60; days to birth: -21951; days to death: 572; ethnicity: not hispanic or latino; gender: female; race: white; vital status: Dead; year of birth: 1939; year of death: 2000; age at diagnosis: 21951; ajcc pathologic m: M0; ajcc pathologic n: N0; ajcc pathologic stage: Stage II; ajcc pathologic t: T2; ajcc staging system edition: 6th; classification of tumor: not reported; days to diagnosis: 0; icd 10 code: C45.0; last known disease status: not reported; morphology: 9052/3; primary diagnosis: Epithelioid mesothelioma, malignant; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Pleura, NOS; synchronous malignancy: No; tissue or organ of origin: Pleura, NOS; tumor grade: Not Reported; year of diagnosis: 1999; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 4903; initial weight: 320.0; sample id: a379ff0d-3a57-4e8a-b755-5f906058f8c1; sample submitter id: TCGA-MQ-A4LI-01A; portion id: 0b8718d2-0b7f-4bbf-b400-c90e44f14955; portion submitter id: TCGA-MQ-A4LI-01A-11; slide id: cb9297de-ab5c-484f-a044-09a14d5758be; slide submitter id: TCGA-MQ-A4LI-01A-01-TS1; percent lymphocyte infiltration: 2.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 0.0; percent tumor cells: 100.0; percent tumor nuclei: 70.0; section location: TOP;